An indication is the approved disease, condition, or clinical situation for which a medicine, biologic, or medical device is intended to be used in a defined patient population. In product information and regulatory submissions, indications are stated in labels, summary-of-product-characteristics documents, prescribing information, clinical study reports, and advertising materials, where precise wording determines the authorized scope of use and off-label boundaries.
Localization teams translate indication statements in prescribing information, package inserts, clinical trial protocols, health authority submission dossiers, and promotional materials for healthcare professionals. The wording must remain aligned with approved labeling in the source market, while still meeting local regulatory terminology and plain-language requirements for patients, prescribers, and review assessors.
A common mistake is expanding or narrowing the indication by changing qualifiers such as 'for the treatment of' to 'for the prevention of' or omitting patient population limits. This can create off-label promotion risks, make the translated label inconsistent with the approved evidence, and trigger regulatory enforcement in the target market.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →